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Jiménez-Barbero J, Gironès N, Abrusci C, ISOLATION AND CHARACTERIZATION OF AN
EXOPOLYMER PRODUCED BY BACILLUS LICHENIFORMIS: IN VITRO ANTIVIRAL
ACTIVITY AGAINST ENVELOPED VIRUSES, Carbohydrate Polymers (2020),
doi: https://doi.org/10.1016/j.carbpol.2020.116737
This is a PDF file of an article that has undergone enhancements after acceptance, such as
the addition of a cover page and metadata, and formatting for readability, but it is not yet the
definitive version of record. This version will undergo additional copyediting, typesetting and
review before it is published in its final form, but we are providing this version to give early
visibility of the article. Please note that, during the production process, errors may be
discovered which could affect the content, and all legal disclaimers that apply to the journal
pertain.
© 2020 Published by Elsevier.
1 
 
ISOLATION AND CHARACTERIZATION OF AN EXOPOLYMER PRODUCED BY 
BACILLUS LICHENIFORMIS: IN VITRO ANTIVIRAL ACTIVITY AGAINST 
ENVELOPED VIRUSES  
 
E. Sánchez-León1,a, R. Bello-Morales1, 2,a, JA. López-Guerrero1, 2, A. Poveda3, J. Jiménez‐
Barbero3,4, N. Gironès1, 2 C. Abrusci 1, 2 
 
1 Departamento de Biología Molecular, Facultad de Ciencias, Universidad Autónoma de Madrid, 
UAM, Cantoblanco, 28049 Madrid, Spain. 
2 Centro de Biología Molecular Severo Ochoa, CSIC-UAM, Madrid, Spain. 
3 CIC bioGUNE, Basque Research and Technology Alliance-BRTA, Parque Científico 
Tecnológico de Bizkaia, 48160, Derio, Biscay, Spain. 
4 Ikerbasque, Basque Foundation for Science, 48009 Bilbao, Biscay, Spain. 
 
a equal contribution 
*Corresponding authors: 
















 B. licheniformis produced an EPSp composed of polyglutamic acid and teichoic acid. 
 The negative charge content of the EPSp increased its electrostatic properties. 
 The EPSp was efficient at inhibiting viral entry against enveloped viruses. 
 The EPSp could have potential applications as a prophylactic therapeutic biomolecule. 
 
Abstract 
The exopolymer (EPSp) produced by the strain B. licheniformis IDN-EC was isolated and 
characterized using different techniques (MALDI-TOF, NMR, ATR-FTIR, TGA, DSC, SEM). 
The results showed that the low molecular weight EPSp contained a long polyglutamic acid and 
an extracellular teichoic acid polysaccharide. The latter was composed of poly(glycerol 
phosphate) and was substituted at the 2-position of the glycerol residues with a αGal and 
αGlcNH2. The αGal O-6 position was also found to be substituted by a phosphate group.  The 
antiviral capability of this EPSp was also tested on both enveloped (herpesviruses HSV, PRV and 
vesicular stomatitis VSV) and non-enveloped (MVM) viruses. The EPSp was efficient at 
inhibiting viral entry for the herpesviruses and VSV but was not effective against non-enveloped 
viruses. The in vivo assay of the EPSp in mice showed no signs of toxicity which could allow for 
its application in the healthcare sector. 
Keywords: Bacillus licheniformis, poly(γ-glutamic acid), teichoic acids, antiviral, enveloped 
viruses  
1. Introduction 
The rapid appearance of microorganisms that can cause zoonotic diseases can cause severe health 
problems as, due to their sudden emergence, there typically are no vaccines available to counteract 
them. In the last two decades, two novel zoonotic viruses have emerged causing fatal epidemics 
in humans: the severe acute respiratory syndrome coronavirus (SARS-CoV), and the Middle East 
(MERS-CoV), which appeared in 2002 and 2012 respectively.  Most recently, the SARS-CoV-2 











which has posed a serious threat to global health and economy. In the cases where the mechanisms 
of action of the pathogen are not well known, these can lead to the collapse of whole countries’ 
health systems. It is therefore necessary to research and implement antiviral compounds that have 
effects on a broader spectrum in order to prevent and combat possible pandemics. This type of 
antiviral treatments can effectively and rapidly reduce infection rates (Harrison, 2020)  
These antiviral compounds can be obtained through biotechnological processes undertaken by 
microorganisms that can adapt to different environments. This is the case of bacteria that can 
produce and secrete extracellular polymeric substances (EPS) with a highly heterogeneous 
composition (More, Yadav, Yan, Tyagi, & Surampalli, 2014). These compounds play a role in 
the protection against desiccation, predation by protozoans and viruses and in the survival in 
nutrient-starved environments  (Panosyan, Di Donato, Poli, & Nicolaus, 2018). These polymers’ 
attributes have led to their use in a wide range of applications in different industrial sectors (Ates, 
2015; Donot, Fontana, Baccou, & Schorr-Galindo, 2012).Their antimicrobial properties have 
been the focus of past research (Yu, Shen, Song, & Xie, 2018) and, in particular, several studies 
have reported the antiviral effect on several viruses. These include herpes simplex type 1 (HSV-
1) (Gugliandolo et al., 2015; Marino-Merlo et al., 2017), herpes simplex type 2 (HSV-2) (Arena 
et al., 2006), encephalomyocarditis virus (EMCV) (Yim et al., 2004), influenza virus (Zheng, 
Chen, Cheng, Wang, & Chu, 2006), infectious hematopoietic necrosis virus (IHNV) and 
infectious pancreatic necrosis virus (IPNV) (Nácher-Vázquez et al., 2015).  
The lack of efficient drugs to treat fast emerging pandemics makes it imperative to speed up the 
research for antiviral agents that are effective against future viral threats. This study reports the 
finding of a novel EPSp composed of Poly-γ-glutamic acid and an extracellular teichoic acid   
polysaccharide (Birch, Van Calsteren, Pérez, & Svensson, 2019).  This EPSp was isolated and 
characterized from B. licheniformis and it was found to exhibit a drastic inhibitory activity in cell 
cultures against multiple human and animal viruses. The EPSp was applied to four enveloped 
viruses (HSV-1 and HSV-2 which infect humans and PRV and VSV which infects animals); and 











when used against enveloped viruses as it significantly reduced the viral yield. This EPSp has 
been proven to be non-toxic in mice and, given its potent antiviral capability in vitro, it is proposed 
as a good candidate for further studies in cell cultures with other enveloped viruses and potentially 
in animal models, in order to establish its efficacy in vivo against enveloped viral infection.  
2. Materials and methods 
2.1. Chemicals and standards 
The anti-HSV gD LP2 antibody was sourced from Alexa555, conjugated secondary anti-mouse 
and anti-rabbit antibodies were sourced from Molecular Probes (Eugene, OR, USA), and Mowiol 
was obtained from Calbiochem (Merck Chemicals, Germany). The rest of reagents were 
purchased from Sigma Chemical Co. (St. Louis, MO, USA).  
2.2. Bacterial strain 
The indigenous bacterial strain, Bacillus licheniformis IDN-EC, had been isolated from films 
based on Poly(Butylene Adipate-co-Terephthalate) and its blend with Poly (Lactic Acid) (Morro, 
Catalina, Sanchez-León, & Abrusci, 2019).  
2.3. Production of exopolymer 
Bacillus licheniformis IDN-EC was inoculated from the stock culture in trypticase soya agar 
medium (TSA) and incubated at 45 ºC for 24 h. After that, the strains were transferred into flasks 
of 100 ml filled with 20 ml of minimal growth medium (MGM), prepared as described by Abrusci 
et al (Abrusci et al., 2011).: g/L: K2HPO4 0.5, KH2PO4 0.04, NaCl 0.1, CaCl2 2H2O 0.002, (NH4) 
2SO4 0.2, MgSO4 7H2O 0.02, FeSO4 0.001, and glucose as a carbon source at a concentration of 
10 g/L, pH adjusted to 7.0. The flasks were incubated in a rotary shaker incubator (Biogen) at 
45ºC and 110 rpm for 24 h. After the first incubation, 10 ml of this broth (2.5 × 107 cells/ml 
concentration) was inoculated into flasks of 1000 ml filled with 100ml of MGM with glucose 
supplementation. The flasks were incubated at 45ºC and 110 rpm for 48 h, when the stationary 










2.4. Biodegradation, cell growth, and pH 
The biodegrading bacteria were evaluated by indirect impedance measurements. The aerobic 
biodegradation of glucose compound by B. licheniformis was performed at 45°C. The bioassays 
were carried out in bioreactors of 7 ml, filled with 1.5 mL of bacterial suspension prepared as 
described above. These containers were introduced into disposable cylindrical cells of 20 mL 
filled with 1.5 mL of 2 g/L KOH aqueous solution and provided by four stainless steel electrodes 
to measure impedance on a Bac-Trac 4300 apparatus (SY-LAB Geräte GmbH, Neupurkerdorf, 
Austria). The method has a typical error in the measurements of 1–2%. The experimental device 
and procedure have been previously described in the literature (San Miguel, Peinado, Catalina, & 
Abrusci, 2009). The device monitors the relative change (each 20 min) in the initial impedance 
value of KOH solution, which is converted in concentration of carbon dioxide by a calibration 
curve of impedance variation versus concentration of CO2. The percentage of biodegradation of 
glucose was calculated as a percentage of the ratio between the cumulative amount of CO2 
produced in the biodegradation at time, t, and the theoretical amount of carbon dioxide assuming 
that all the carbon of the glucose structures introduced in the bioreactor are transformed into CO2.  
% Biodegradation = ([CO2]Prod/[CO2]Theor.) × 100. 
The cell growth number was evaluated by different dilution plating incubated at 45ºC for 48 h 
with TSA agar medium. A Thermo Orion pH Meter (model, 2 Star) was used to determine the pH 
values during a fermentation period of 48 h. 
2.5. Isolation and purification of the EPS  
The cultures obtained from the strain B. licheniformis IDN-EC were centrifuged at 13,154 × g for 
30 min at 4ºC (Duppont - RC5). The EPS was precipitated with cold ethanol (three times the 
volume) and left overnight. The precipitate was collected by centrifugation at 13,154 × g for 30 
min at 4ºC and dissolved in Milli-Q water. Then the crude EPS was dialyzed at 4ºC with Milli-Q 
water for 48 h. The dialyzed contents were then freeze dried by lyophilization for 48 h and the 











The further purification of crude EPS (10 mL, 10 mg/mL) was subjected to a DEAE-52 anion 
exchange column (2.6×30 cm) and eluted with deionized water, 0.05 and 0.3 M NaCl at 1 mL/min 
flow rate.  
2.6. Mass Spectrometry 
MALDI-TOF mass spectra were recorded on an Ultraflex III TOF/TOF mass spectrometer 
(BrukerDaltonics) equipped with a Nd:YAG laser (355 nm). Mass spectra were recorded in 
positive reflector (range 1-10 KDa) and lineal (range 1-20 KDa) modes, using a matrix of 
10mg/mL 2,5-dihydroxibenzoic acid (DHB) in methanol/water (90/10). 
2.7. Monosaccharide Analysis 
To determine the monosaccharide composition, the EPSp was hydrolyzed with trifluoroacetic 
acid (TFA) 0,5M at 120°C for 2 h. The samples were treated before and after the process with N2. 
The monosaccharide content of EPSp was analyzed by HPLC using a 920LC Varian apparatus 
equipped with a PL-EDS 2100 Ice detector. A sugar SP0810 (Shodex) column as a stationary 
phase was used with an isocratic mobile phase of water as a solvent and a flow rate of 0,5mL/min. 
The column temperature was maintained at 30°C. The samples injection volume was 50 μL. The 
monosaccharide such as glucose, arabinose, rhamnose, xylose, mannose, galactose, fructose and 
sorbose were used as standards. The concentration of glucuronic acid was determined by 
HPLC/MSMS using an Agilent Technologies 1100 series ‐  6410B (TQ).  An ACE Excel 3 C18-
Amide column as a stationary phase was used with a mobile phase of 0, 1% formic acid in water.  
Flow rate of 0,2ml/min. The temperature for analysis was set at 40 °C. 
2.8. NMR Spectroscopy 
For NMR sample preparation, ca 4 mg of the EPSp sample were dissolved in 0.5 ml of deuterated 
water D2O. NMR spectra were acquired using either a Bruker AVIII-600 spectrometer equipped 
with a 5mm PATXI 1H/D-13C/15N XYZ-GRD probe (for 1H and 13C experiments) or a 5 mm 











a cryoprobe 5mm CPTCI 1H-13C/15N/D Z-GRD. All experiments were recorded using standard 
Bruker pulse sequences and the temperature was set at 298K. Chemical shifts are expressed in 
parts per million (, ppm) with respect to the 0 ppm point of DSS (4-dimethyl-4-silapentane-1-
sulfonic acid), used as an internal standard.  
The composition of the sample and the structure of the compounds was determined using a 
combination of 1D (1H, 1D-selective TOCSY, NOESY and ROESY experiments) and 2D 
(DOSY, COSY, 1H-13C-HSQC, 1H-13C-HSQC-TOCSY, 1H-31P-HMBC) NMR experiments. For 
the 1H-13C -HSQC experiment, values of 10 ppm and 2K points, for the 1H dimension, and 90 
ppm and 256-512 points for the 13C dimension, were used. For the homonuclear COSY 
experiment, 8 ppm windows were used with a 1K x 256-point matrix. For the 1D-selective 
NOESY experiments, mixing times of 300 ms were used. For the 1D-selective ROESY 
experiments spinlock times of 300 ms were also used. For the HSQC-TOCSY mixing times of 
80ms were used, while for the 1D- selective version 30-100 ms range was used. For the 1H-31P-
HMBC and 1H-31P-HSQMBC-TOCSY experiments, values of 4-10 ppm and 2K points, for the 
1H dimension, and 8-40 ppm and 128-256 points for the 31P dimension, were used. These 
experiments were optimized for a long-range coupling constant of 10 Hz, and 40ms were used as 
mixing time for the TOCSY version. The DOSY experiment was acquired using the ledbpgp2s 
pulse sequence from the Bruker library. An exponential gradient list of 24 values was created by 
using the standard AU program dosy. Experiments were acquired using 8 scans, δ/2 of 1.8 ms, 
diffusion time ∆ of 500 ms, and eddy current delay value of 5 ms. 
2.9. Attenuated Total Reflectance/FT‑Infrared Spectroscopy (ATR/FTIR). 
Thermogravimetric Analysis 
The structural-functional groups of the EPSp were detected using Attenuated Total 
Reflectance/FT-Infrared Spectroscopy (ATR-FTIR). IR spectra were obtained using a Perkin 










Technologies and interferograms were obtained from 32 scans at a 4 cm–1 with a resolution from 
400 to 4000 cm–1. 
Thermogravimetric analysis (TGA) of the polymer was done using a TGA Q‐500 (Perkin‐Elmer). 
The heating rate for the dynamic conditions was 10°C/min, and the nitrogen flow was maintained 
constant at 60 mL/min. 
2.10. Scanning Electronic Microscopy (SEM) 
Scanning electronic microscopy micrographs were obtained using a Philips XL 30 scanning 
electron microscope operating in conventional high-vacuum mode at an accelerating voltage of 
25 kV. Previously, EPSp was coated with a 3 nm thick gold/palladium layer. 
2.11. Cell lines and viruses 
Vero, HOG, MeWo and Hela cell lines were propagated in DMEM supplemented with 10% FBS, 
penicillin (50 U/mL) and streptomycin (50 μg/mL) at 37°C in an atmosphere of 5% CO2, (Bello-
Morales et al., 2012). The Jurkat cell line was cultured in RPMI 1640 medium supplemented with 
10% FBS, 2 mM glutamine, 1 mM sodium pyruvate, 10 mMHepes, and 100 mg/mL each of 
penicillin and streptomycin as described (Alonso, Mazzeo, Mérida, & Izquierdo, 2007).  
In this study, HSV-1 K26GFP (Desai & Person, 1998), HSV-2, PRV XGF-N (Viejo-Borbolla, 
Muñoz, Tabarés, & Alcamí, 2010), VSV-GFP and MVM viruses were tested. Herpesviruses were 
propagated and titrated on Vero cells. VSV-GFP and MVM viruses were propagated and titrated 
on Hela cells. The virus HSV-1 (KOS) gL86, a β-galactosidase–expressing version of KOS strain 
(Montgomery, Warner, Lum, & Spear, 1996), was used to monitor the viral entry.  
2.12. Viral infection methodology 
To evaluate the effect of EPSp on viral infections, cells were plated in 24-well plates, with or 
without glass coverslips and, 24 h later, confluent monolayers were infected with a mixture of 











prepare the amount necessary for 10 wells and a 5 µg/ml concentration, the virus was incubated 
at a m.o.i. of 0.5 TCID50/ml in a microcentrifuge tube with 10 µl of EPSp  mg/ml (1 µl of EPSp 
per well) in serum-free DMEM as part of a pre-treatment prior to cell infection. The final volume 
was then adjusted to 30 µl and left in the tube for 1 h at 37ºC in a CO2 incubator. After that, 2 ml 
of serum-free DMEM was added to the tube containing the viral inoculum and EPSp. The cells 
were washed with serum-free DMEM, and infected with 200 µl per well of the viral inoculum 
and EPSp mixture resulting in a final EPSp concentration of 5 µg/ml. After 1 h of viral adsorption, 
the inoculum was withdrawn and the cells were washed twice with serum-free DMEN. Finally, 
cells were incubated in DMEM 10% FBS for 24h. The effect of EPSp on viral infection was 
evaluated either by immunofluorescence, flow cytometry or quantification of viral production. 
Viral titer was quantified by an endpoint dilution assay determining the 50% tissue culture 
infective dose (TCID50) in Vero cells. Each experiment was conducted thrice.  
2.13. Viral Assays 
To investigate dose dependent viral infections, the recombinant HSV-1 (KOS) gL86 was used 
which expresses beta-galactosidase upon entry into cells (Yakoub et al., 2014). Vero cells plated 
in 96-well tissue culture dishes were infected at a m.o.i. of 10 with HSV-1 gL86 treated or mock-
treated with two-fold serial dilutions of EPSp at concentrations of 6.25, 12.5, 25 and 50 µg/ml. 
This was prepared following the method described in Section 2.12 and adjusted to obtain the 
desired concentration. After 6 h p.i., the beta-galactosidase activity was analyzed at 410 nm in a 
microplate reader.  
The effect of the EPSp on different HSV-1 infected cell lines was also analyzed. Several adherent 
and non-adherent cell lines were chosen: human HOG, Hela, Jurkat and Mewo cells. These were 
prepared and evaluated following the methodology described in the Section 2.12.    
The effect of the EPSp on different viruses was investigated in Section 2.11. The cells were 
prepared as described in Section 2.12 except for PRV which had an increased base dosage of 10 











additional 2-fold dose. For MVM and VSV, there were additional 5-fold and 4-fold dosages 
respectively.  
2.14. Immunofluorescence microscopy 
Cells grown on glass coverslips were fixed in 4% paraformaldehyde for 20 min and rinsed with 
PBS. Then cells were permeabilized with 0.2% Triton X-100, rinsed and incubated for 30 min 
with 3% bovine serum albumin in PBS with 10% human serum (only for herpes, to block the 
HSV-1-induced IgG Fc receptors). For double and triple-labeled immunofluorescence analysis, 
cells were incubated for 1 h at room temperature with the appropriate primary antibodies, rinsed 
several times and incubated at room temperature for 30 min with the relevant fluorescent 
secondary antibodies. Herpes antibodies were incubated in the presence of 10% human serum. 
Controls to assess labeling specificity included incubations with control primary antibodies or 
omission of the primary antibodies. After thorough washing, coverslips were mounted in Mowiol. 
Images were obtained using an LSM510 META system (Carl Zeiss) coupled to an inverted 
Axiovert 200 microscope. Processing of confocal images was made by FIJI-ImageJ software. 
 
2.15. Flow cytometry analysis. 
To perform FACS analysis, cells were dissociated by incubation for 1 minute in 0.05% 
trypsin/0.1% EDTA (Invitrogen) at room temperature and washed and fixed in 4% 
paraformaldehyde for 15 minutes. Then, cells were rinsed and resuspended in PBS. Cells were 
analyzed using a FACSCalibur Flow Cytometer (BD Biosciences).  
2.16. In vivo toxicity evaluation of EPSp 
To evaluate the toxicity of the EPSp produced by B. licheniformis IDN-EC in vivo, the Balb/c 
mouse model was used. Twenty male Balb/c mice (21-27 days) were purchased from Charles 
River Laboratories España and maintained at the Animal Facility of the Centro de Biología 











mice were randomly distributed in 4 cages of 5 individuals and mock-inoculated or inoculated 
intraperitoneally with 100 µl of different concentrations of EPSp (6, 60 and 600 µg per animal) 
diluted in isotonic saline solution (NaCl 0.9% w/v) from FisioVet (B. Braun VetCare, Barcelona, 
Spain). The control consisted of 100 µl of the same saline solution. After injection of the acute 
dose of EPSp, mice were allowed free access to food and water and monitored daily for morbidity, 
mortality and behavioral changes. At day 14, mice were sacrificed by CO2 and exsanguinated by 
cardiac puncture to obtain whole blood, in order to analyze their blood profiles and counts. Several 
parameters were analyzed to monitor renal, hepatic and immunologic basic profiles. For the 
biochemical analyses, urea, total protein, alanine aminotransferase (ALT) and bilirubin levels 
were studied. For hematologic analysis, the percentage of lymphocytes and segmented 
neutrophils was measured, as well as the WBCs count. The body weight gain from the day 0 
(inoculation) to the day 14 (sacrifice) was also quantified, to exclude a weight loss or failure to 
gain weight that would be indicative of toxicity. 
2.17. Statistical analysis 
Student's t-test was used to determine differences between groups. All data are represented as 
mean ± standard deviation.  
2.18. Ethics statement 
This study was carried out in strict accordance with the European Commission legislation for the 
protection of animals used for scientific purposes (directives 86/609/EEC and 2010/63/EU). Mice 
were maintained under specific pathogen-free conditions at the CBMSO (CSIC-UAM) animal 
facility. The protocol for the treatment of the animals was accepted by the “Comité de Ética de la 
Investigación” of the Universidad Autónoma of Madrid, Spain and approved by the “Consejería 
General del Medio Ambiente y Ordenación del Territorio de la Comunidad de Madrid” (PROEX 
148/15). Animals had unlimited access to food and water, and at the conclusion of the studies 
they were euthanized in a CO2 chamber, with every effort made to minimize their suffering, 













3.1. Biodegradation, cell growth, pH, and EPS production 
The growth of B. licheniformis IDN-EC, medium biodegradation, pH values and exopolymer 
production (EPS) at 45ºC, are shown in Fig. 1a.  Cellular growth peaked (9.35 log cfu / ml) after 
30 h. In this moment, the strain completely biodegraded the glucose as a carbon source. The 
maximum production of EPS, 60 mg/ L, occurred after 42 h. During the process no acute pH 
descent was detected, as the acidification of the medium was very low (from pH 7 to just 6.6). 
3.2. Characterization of exopolymer 
The results of the obtained fraction from the purified exopolymer was named as EPSp.  This was 
found to be water soluble and colorless. The mass spectrum of the polymer indicated that it had 
an approximate molecular weight of 5kD (Fig. 1b). HLPC analysis of EPSp, showed that this was 













Fig. 1. Characterization of the exopolymer EPSp extracted from B. licheniformis IDN-EC. 
a) Time course of glucose biodegradation, colony-forming unit (CFU), pH value, and EPSp 













The NMR analysis (table 1 and fig.2 (1-2)) showed the presence of three groups of signals and 
two different types of molecules with different molecular sizes. The first one is a saccharide as 
observed in the 1H-NMR spectrum where two anomeric protons can be distinguished, with J 
couplings of 3.5 and 3.9 Hz, indicative of α type linkages.  
However, there are additional signals, below 3 ppm, which do not correspond to a sugar and that 
are compatible with a peptide, mostly composed by aliphatic amino acid side chains. Diffusion 
Ordered NMR experiments (DOSY) showed the existence of two different molecules with 













Fig. 2.1. Nuclear magnetic resonance (NMR) analysis of the exopolymer EPSp. a) DOSY 
NMR experiment showing the presence of two components in the mixture with different diffusion 
coefficient times and therefore, different molecular weights. b) 1H-13C HSQC NMR spectrum 
showing the signals assignment of the diverse molecules in the sample.  
The peptide component shows a typical -CH(α)-CH2(β)-CH2(γ) pattern, as determined by COSY 
and HSQC-edited experiments. Both CH(α) and CH2(γ) signals correlated with carbonyl signals 
in the 1H-13C HMBC experiments, at  181 and 178 ppm respectively. The γ-linkage of the Glu 
chain was determined by comparison with the previously described product (Kino, Arai, & 
Arimura, 2011). Thus, the peptide component could be identified as polyglutamic acid (γ-PGA), 
which displayed the highest molecular weight. 
Regarding the carbohydrate-containing molecule, the detailed analysis was based on the 
combination of COSY, HSQC, HSQC-TOCSY and 1D-selective TOCSYs experiments  (fig 2.2). 
This protocol allowed identifying the two constituent sugar residues. The signals for the major 
component showed a typical Gal pattern: The 1D-selective TOCSY experiments from the 
anomeric proton demonstrated the complete H1-H2-H3-H4 spin system, which is stopped at H4 
due to the small H4-H5 coupling. This behavior is typical for Gal moieties. Moreover, the 13C 
chemical shift for C-6 indicated that this OH position was substituted. As observed in the 1H-31P 
HMBC and HSQCMBC-TOCSY experiments, phosphorylation of Gal sugar moiety at position 
6 was confirmed due to the TOCSY correlation of this signal with Gal-H5 position. 
The minor component showed a drastically different coupling pattern in the 1D-selective TOCSY, 
with typical glucose-type couplings: large vicinal 1H-1H J values. In this case, the position C2 in 
the HSQC showed the typical chemical shift of a carbon attached to a nitrogen atom, instead of 
oxygen. Since no methyl signals for a putative acetyl group were evidenced in the regular 1H or 
in the HSQC or in the HMBC spectra, the minor component was identified as an αGlucosamine 











were identified. However, they only displayed 15% of the intensity of that expected for a methyl 
acetate with respect to those belonging to the H1C1 or H2C2 signals of the minor component in 
the same spectrum. Given that the intensities of the methyl groups are usually magnified thanks 
to its fast motion features, the presence of N-acetylation should be basically negligible. 
In addition to these monosaccharide moieties, NMR signals for glycerol esters were identified 
with different substitution patterns. From HSQC-edited and HSQC-TOCSY experiments, three 
CH and four CH2 glycerol signals were identified. The substitution was deduced from the analysis 
of the 13C chemical shifts, which allowed differentiating one unsubstituted signal for each group. 
From the TOCSY correlations it was possible to establish three different substitution patterns in 
the glycerol subunit: at 1-2 (one OH free, terminal position of the chain), 1-3 and 1-2-3 OHs 
(internal positions of the chain). 1D-selective NOESY experiments from both anomeric positions 
allowed correlating the GlcN H1 to the position 2 of the 1-2-3 substituted glycerol moiety and the 
Gal H1 signal to the position 2 of the 1-2 substituted unit. This structure was fully compatible 
with other poly glycerol phosphates as previously described (Tul’skaya, Vylegzhanina, 
Streshinskaya, Shaskov, & Naumova, 1991). 
With this information it is proposed that the composition of the major products of the sample is 
the following. 
-A long polyglutamic acid with the largest molecular weight. 
-A polyglycerol phosphate chain O-substituted with αGal moieties at terminal positions and 
further modified with αGlcNH2. Given the approximate αGal/αGlcNH2 3:1 molar ratio and 
considering that the αGal is at the terminal position, some chains do not display αGlcNH2 units. 











Fig. 2.2. Nuclear magnetic resonance (NMR). Different heteronuclear 2D experiments were 
employed to determine the composition and structure of the exopolymer EPSp: a) 1H-13C 
HSQC-TOSCY, b) 1H-13C HSQC edited, c) 1H-31P HMBC, and d) 1H-31P HSQMBC-TOCSY. 
Signals corresponding to H5/C5 and H6/C6 cross peaks of Gal are labelled in spectra b), c), and 
d), assessing the presence of phosphate at Gal O6. e) Proposed idealized structures of the 
molecular components of the sample. 
 
The FT-IR spectroscopic analysis was applied to disclose the polar bonds and the different atom 
vibrations of the molecules. The results showed (Fig. 3a)  the presence of the characteristic bands 
for poly glutamic acid (γ-PGA) (Mohanraj et al., 2019). The IR spectra of the EPSp of B. 
licheniformis IDN-EC  exhibited a broad peak at around 3270 cm -1 (range 3600-3200 cm -1) for 











Fernández, Rodríguez-Vázquez, Tojo, & Andrade, 2003). The peak at 1582 cm-1 was associated 
to the deformation vibration of an amide group (Sardari et al., 2017). The band at 1399 cm -1 was 
assigned to the group C=O whereas the peak at 1052 cm -1was associated to the C-N group. On 
the other hand, polyphosphate groups  were assigned to the presence of characteristic bands at 
1219cm -1, (range 1200-900)cm -1), (Grunert et al., 2018) this belonged to the teichoic acid 
polysaccharide. 
Thermogravimetric analysis (TGA) was used to investigate the thermal stability in the inert 
atmosphere of EPSp obtained from B. licheniformis IDN-EC. The EPSp degradation process took 
place by reduction of average molecular mass weight. The decomposition of the exopolymer 
started at 242.4ºC and 36% of weight loss was observed at 357.41ºC. The differential scanning 
calorimetry (DSC) (Fig. 3b) for EPSp showed exothermic peak for crystallization temperature 
(Tc) at 272.66.77 °C and the other two peaks formelting temperatures at Tm1 = 356,79 °C and 
Tm2 = 423,90 °C. The EPSp was highly crystalline.  Therefore, it was a notably thermostable 
biopolymer. The morphology of the EPSp obtained from B. licheniformis IDN-EC was studied 
using scanning electron microscopy (SEM) (Fig. 3c). A three-dimensional structure was observed 
with structural units in the form of thin scales of different sizes intertwined with fine fibers, 













Fig. 3. ATR-FTIR spectra, thermal analysis and ultrastructural characterization of the 
exopolymer EPSp. a) ATR-FTIR spectra. b) Thermogravimetric analysis and DSC thermogram. 
c) Scanning electron micrographs 
 
3.3. Effect of EPSp on herpesvirus infection 
The antiviral activity of the exopolymer was assessed using the procedures described in Section 











The immunofluorescence assays showed an almost complete disappearance of the GFP signal in 
cells infected with EPSp-treated virus at 24 h p.i. with a 5µg/ml dose (Fig. 4a).  To quantify the 
effect of exopolymer on viral yield, progeny virus was titrated to determine the TCID50/ml. After 
24 h p.i., viral yield in Vero cells infected with EPSp-treated virus decreased around 5 orders of 
magnitude compared to cells infected with mock-treated virus, to become practically undetectable 
(Fig. 4b). 
To investigate whether the decrease in viral yield was due to a decrease in viral entry, Vero cells 
were infected with the recombinant HSV-1 (KOS) gL86 and treated or mock-treated with two-
fold serial dilutions of EPSp as described in Materials and Methods (Viral entry section). After 6 
h p.i., the beta-galactosidase activity finding a significant (p<0.05) dose dependent decrease of 












Fig. 4. Exopolymer EPSp extracted from B. licheniformis IDN-EC on HSV-1 infection of 
Vero cell lines. a) Immunofluorescence images of cells show the GFP signal associated to HSV-
1 K26.. b). Progeny virus was titrated 24 h p.i. to determine the 50% tissue culture infective dose 
(TCID50)/ml. Histogram shows the viral production cells infected with the control virus (W/O) 
and the EPSp treated virus (EPSp). c) Histogram shows HSV-1 gL86 pre-treated and the control 
with two-fold serial dilutions of EPSp 1 mg/ml, at final concentrations of 6.25, 12.5, 25 and 50 
µg/ml. After 6 h p.i., the beta-galactosidase activity at 410 nm was analyzed using a microplate 











Experiments performed with the rest of cell lines, HOG (Fig. 5a), Mewo (Fig. 5b), Hela (Fig. 5c) 
and Jurkat (Fig. 5d), showed similar results: immunofluorescence assays showed a drastic 
decrease of GFP signal in cells infected with EPSp-treated virus at 24 h p.i. and, in addition, viral 
progeny decreased around 4-5 orders of magnitude (depending on the infectivity of the cell lines) 












Fig. 5. Effect of exopolymer EPSp extracted from B. licheniformis IDN-EC on HSV-1 
infection of human cell lines. Immunofluorescence images show the GFP signal associated to 
HSV-1 K26 in a) HOG, b) Mewo, c) Hela, and d) Jurkat cells. e) Progeny virus was titrated 24 h 
p.i. to determine the 50% tissue culture infective dose (TCID50)/ml. Histogram shows the viral 
production of HOG, Mewo, Hela and Jurkat cells infected with the control virus (W/O) and the 
EPSp treated virus (EPSp). (scale bar=5µm, n=3, * p<0.05). 
 
To analyze whether the results previously shown could be extrapolated to other herpesviruses, 
Vero cells were infected with HSV-2 and PRV-GFP XGF-N (Fig. 6) at a m.o.i. of 0.5.  Infection 
with HSV-2 (Fig. 6a) treated with EPSp at 5 µg/ml showed only a moderate decrease compared 
to mock-treated control. However, with HSV-2 treated with EPSp at 10 µg/ml, infection 
drastically decreased. On the other hand, infections with PRV-GFP XGF-N at an m.o.i. of 0.5 
yielded similar results at 24 h p.i., although the effect of EPSp on PRV infection was less 
pronounced (Fig. 6b). Thus, infection with PRV-GFP XGF-N treated with EPSp at 10 µg/ml did 
not caused any observable effect compared to mock-treated control and, to inhibit infection, a 
dose of EPSp at 20 µg/ml was needed (Fig. 6b). Similarly, quantification of viral production with 
HSV-2and PRV-GFP XGF-N, both treated with same doses EPSp (20 µg/ml) showed a decrease 












Fig. 6. Exopolymer EPSp extracted from B. licheniformis IDN-EC on HSV-2 and PRV-GFP 
infection of Vero cell line. Immunofluorescence images show a) the monoclonal anti-HSV gD 
b) GFP signal associated to PRV-GFP in Vero cells. c-d) Histogram shows the viral production 
cells infected with HSV-2 and PRV-GFP XGF-N for both the control virus (W/O) and the EPSp 
treated virus (EPSp). Both were treated with same doses EPSp (20 µg/ml) showed a decrease of 












3.4. Effect of EPSp on other enveloped (VSV) and non-enveloped (MVM) viruses 
To analyze whether the results above described could be extrapolated to another enveloped virus, 
cells were infected with VSV-GFP at a m.o.i. of 0.5. As shown in Fig. 7a, the decrease of VSV 
infection was most noticeable with an EPSp dose of 20µg/ml. In addition, flow cytometry analysis 
showed a 4-fold reduction in the viral-GFP signal of cells infected with VSV-GFP treated with 
EPSp 20 µg/ml when compared to non-treated control, and 2-fold reduction when compared to 






















Fig. 7. Effect of exopolymer EPSp extracted from B. licheniformis IDN-EC on VSV-GFP 
infection of Hela cell line. a) Immunofluorescence images of cells show the GFP signal 
associated to VSV -GFP b) flow cytometry analysis and histogram showed the fold reduction.  
The control virus (W/O) and the EPSp treated virus (EPSp). (scale bar=10µm, n=3 p<0.05). 
 
Finally, the EPSp was tested on a non-enveloped virus, MVM. Hela cells were infected with EPSp 
treated or mock-treated MVM. After 24 h p.i., no change in viral-associated signal was observed 
in the cells as shown by the immunofluorescence images and the accompanying histogram 
quantification (Figs. 8a and 8b). 
 
 
Fig. 8. Effect of exopolymer EPSp extracted from B. licheniformis IDN-EC on MVM 
infection of Hela cell line. a) Immunofluorescence images of cells with the anti-VPs MVM 
polyclonal antibody followed by an Alexa-555 donkey anti-rabbit secondary antibody. b) 
Histogram shows the percentage of cells infected with the control virus (W/O) and the EPSp 












3.5. In vivo toxicity evaluation of EPSp in mice 
Twenty male Balb/c mice were mock-inoculated or inoculated with different single doses of the 
EPSp Section 2.11. Several parameters were analyzed. For the biochemical analysis, levels of 
urea (Fig. 9a), total protein (Fig. 9b), alanine aminotransferase (ALT) (Fig. 9c) and bilirubin (Fig. 
9d) were measured. For hematologic analysis, the percentage of lymphocytes (Fig. 9e), the white 
blood cells (WBCs) count (Fig. 9f) and segmented neutrophils (Fig. 9g) were evaluated. For 14 
days there were no significant changes in any of the parameters between the control and 
experimental groups. No toxic signs were observed such as hypothermia, weakness, diarrhea or 













Fig. 9. In vivo toxicity evaluation of EPSp. Twenty male Balb/c mice were randomly distributed 
in cages of 5 individuals and inoculated or mock-inoculated intraperitoneally with 100 µl of ten-
fold concentrations of EPSp diluted in NaCl 0.9% w/v: 6, 60 and 600 µg of EPSp per animal. At 











biochemical analyses, urea (a), total protein (b), ALT (c) and bilirubin (d) levels were tested. For 
hematologic study, the percentages of lymphocytes (e), WBCs count (f) and segmented 
neutrophils (g) were analyzed. The body weight gain was also monitored (h). Control: 100 µl of 
NaCl 0.9% w/v per animal. (ALT: alanine aminotransferase; WBC: white blood cells). 
 
4. Discussion 
The aim of this work was to isolate and characterize a natural exopolymer produced by B. 
licheniformis IDN-EC strain and to evaluate its role as a potential antiviral agent.  
During the polymer production process (Fig. 1a), essential factors like the carbon and nitrogen 
sources, aeration, agitation and medium pH were controlled. These factors can have an important 
effect on the quantity and quality of the polymer (Kongklom, Luo, Shi, & Pechyen, 2015). The 
characterization assays conducted on the produced polymer (EPSp) (figs. 2 and 3a) identified two 
components: Poly-γ-glutamic acid (γ-PGA) and an extracellular teichoic acid (EC-TA). 
γ-PGA is an anionic polymer due to the presence of carboxylic groups that can interact 
electrostatically with positive charges (Pereira et al., 2017). These have been found to be secreted 
by different species of the Bacillus genus, such as B. licheniformis and B. subtilis (Bajaj & 
Singhal, 2011) and have been described to have antiviral properties but this is only for high 
molecular weights (Lee et al., 2013).  
The teichoic acid polysaccharide was composed of polyphosphate and was substituted at the 2-
position of glycerol residues with a αGal, αGlcNH2. In addition to this, the αGal O-6 position was 
substituted by a phosphate group. This polysaccharide can be identified as a teichoic acid due to 
the presence of the polyphosphate compound. A teichoic acid is a polysaccharide that is only 
produced by gram-positive bacteria. An unusual trait of this teichoic acid is that it is extracellular 
(EC-TA) since this type of TA has only been described in a limited number of species (Xiao & 











found to be atypical due to the nature of its charges (Weidenmaier & Peschel, 2008). These only 
contain negatively charged phosphate groups and positive charges are absent, this has only been 
previously described for Bacillus subtilis. In addition to this, the substitution by phosphate groups 
in the O-6 position of the αGal would increase the electrostatic properties of the EC-TA. It has 
been found with other compounds that when the αGal O-6 position is substituted with negative 
charges such as sulphates, there is an increase in the antiviral capability of these (Ghosh et al., 
2009). The significant negative overall charge of the two polymer components of the EPSp (the 
γ-PGA and the EC-TA) would have a synergy effect thus increasing the antiviral effect of the 
polymer. 
The molecular weight of the EPSp, (5kDa) (fig. 1b) is similar to the pentosan polysulphates (3 
kDa), and dextran sulphates (5 kDa) (Mbemba, Chams, Gluckman, Klatzmann, & Gattegno, 
1992). These compounds with a high number of negative charges have previously been described 
as highly effective in inhibiting the replication of enveloped viruses and ineffective against non-
enveloped viruses (Wang, Wang, & Guan, 2012).  As well as a low molecular weight, the 
morphology of the polymer can ease contact. The natural scaffold of the B. licheniformis IDN-
EC EPSp presented a non-uniform morphology (fig. 3c). This is especially relevant as a non-
uniform surface could promote viral contact, in a similar way to cell adhesion. This would in turn 
favor the polymer-virus interaction and significantly increase the efficiency of antiviral activity 
(De Colli et al., 2012)..  
The antiviral capability of this EPSp was tested by infecting Vero cells with HSV-1 K26-GFP 
and varying the dose and cell type. HSV-1 was pretreated with the EPSp prior to cell infection. 
The titration results and the immunofluorescence images confirmed that the EPSp has a virucidal 
dose-dependent effect in the viral entry as the EPS was more effective with larger doses (Fig. 4) 
(Schnitzler, Schneider, Stintzing, Carle, & Reichling, 2008). The effectiveness against different 
cell lines also suggested that the EPS could inhibit the first step of viral infection by preventing 











The antiviral capability of this EPSp was also tested on both enveloped (herpesviruses and VSV) 
and non-enveloped (MVM) viruses. The obtained differences in inhibition efficiency of the EPSp 
among the herpesviruses (HSV-1 (5 µg/ml ) >HSV-2 ( 10 µg/ml )  >PRV (20 µg/ml) (figs. 4 and 
6) and VSV, (20 µg/ml) (fig. 7) could be due to the different capabilities of the viral glycoproteins 
to establish unspecific electrostatic bonds. HSV-1 has been found to be most effective in 
establishing this type of bonds with the cells that it infects (Ho, Jeng, Hu, & Chang, 2000). The 
EPSp did not present any antiviral effects against MVM (Fig. 8). This suggests that the antiviral 
properties might be a universal phenomenon against enveloped viruses which would make the 
EPSp a potential antiviral treatment against other enveloped viruses such as SARS-CoV-2. 
Furthermore, the in vivo assay of the EPSp in mice showed no signs of toxicity (Fig. 9). 
5. Conclusion 
This study demonstrates that the exopolymer produced by B. licheniformis IDN-EC was 
composed of Poly-γ-glutamic acid and a teichoic acid. The negative charge content increased the 
electrostatic properties of the EPSp. This meant that the EPSp was highly effective as an antiviral 
treatment against a group of human and animal enveloped viruses. This further suggests that the 
novel EPSp could be a good candidate for further studies in cell cultures with other enveloped 
viruses. The in vivo results also imply that there is a potential application in the pharmaceutical 
industry as a prophylactic therapeutic biomolecule. Future tests in animal models would establish 
its efficacy in vivo against enveloped viral infection.  
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Table 1: δH, δC and δP values (ppm) obtained from the analysis of the 1H-13C HSQC and 
HMBC NMR experiments. (a) There are three groups of signals in the 31P spectra at δP 3.15, 3.26, 
and 3.48 ppm that correlate with the corresponding CH2 groups in the 1H-31P HMBC NMR 
spectrum. 
 CH(α) CH2(β) CH2(γ) CO(α) CO(γ)   







180.0 177.8  
 
 CH2(1) CH(2) CH2(3) 31P(a)    
PolyGlycerol [1,2] 








3.48   
 
PolyGlycerol [1,3] 





















3.48   
 
 CH(1) CH(2) CH(3) CH(4) CH(5) CH2(6) 31P(a) 
αGal 
5.2 
101.2 
3.8 
71.0 
3.9 
71.8 
4.0 
71.6 
4.3 
72.5 
4.0 
67.3 
3.48 
αGlcN 
5.1 
99.4 
3.9 
56.3 
3.7 
73.7 
3.5 
72.7 
3.9 
74.7 
3.9, 3.8 
63.2 
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